• 

  August 12, 2026

  Bruker Just Bought Control of MIMETAS, and With It, a Seat at the Center of the NAMs Transition

  Ricky Solorzano

• 

  August 11, 2026

  Humacyte Advances Bioengineered Coronary Vessel Into First Human Study

  Ricky Solorzano

• 

  August 7, 2026

  Paragonix’s KidneyVault Pushes Organ Preservation Beyond Geographic Limits

  Ricky Solorzano

• 

  July 13, 2026

  STEMCELL Technologies and CCRM Build a Matched iPSC Path from Research to GMP

  Ricky Solorzano

• 

  June 13, 2026

  BellaSeno’s Mentor/J&J Collaboration Signals a New Chapter for Regenerative Soft-Tissue Implants

  Ricky Solorzano

• 

  May 8, 2026

  restor3d’s Aeros Ankle System Goes Full Commercial, 3D-Printed Orthopaedics Hits the Clinic

  Ricky Solorzano

• 

  May 7, 2026

  Miromatrix’s miroliverELAP Earns RMAT Designation

  Ricky Solorzano

• 

  April 30, 2026

  Eli Lilly Pays Up to $7B for Kelonia’s In Vivo CAR-T Platform and What It Means for Cell Therapy Manufacturing

  Ricky Solorzano

• 

  April 21, 2026

  ARPA-H Is Funding the Regeneration of Human Joints, and the Biofabrication Implications Go Further Than Osteoarthritis

  Ricky Solorzano

• 

  April 8, 2026

  Cellbricks Therapeutics Raises €10M to Advance Biofabricated Tissue Implants for Wound Care and Reconstructive Surgery

  Ricky Solorzano